[Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer].
Robert
J
J
Fondation Bergonié, Bordeaux, France.
David
M
M
Huet
S
S
Chauvergne
J
J
Monnier
A
A
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000652:urine; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*
D000970:Antineoplastic Agents; D004317:Doxorubicin; C027260:pirarubicin
Pharmacocinétique de la pirarubicine (THP-doxorubicine) chez des malades cancéreux.